These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
859 related items for PubMed ID: 17725620
21. Comparison of the abilities of Salmonella typhimurium rpoS, aroA and rpoS aroA strains to elicit humoral immune responses in BALB/c mice and to cause lethal infection in athymic BALB/c mice. Coynault C, Norel F. Microb Pathog; 1999 Jun; 26(6):299-305. PubMed ID: 10343058 [Abstract] [Full Text] [Related]
22. Evaluation of a phoP/phoQ-deleted, aroA-deleted live oral Salmonella typhi vaccine strain in human volunteers. Hohmann EL, Oletta CA, Miller SI. Vaccine; 1996 Jan; 14(1):19-24. PubMed ID: 8821644 [Abstract] [Full Text] [Related]
23. phoP/phoQ-deleted Salmonella typhi (Ty800) is a safe and immunogenic single-dose typhoid fever vaccine in volunteers. Hohmann EL, Oletta CA, Killeen KP, Miller SI. J Infect Dis; 1996 Jun; 173(6):1408-14. PubMed ID: 8648213 [Abstract] [Full Text] [Related]
24. A live Salmonella enterica serovar Enteritidis vaccine allows serological differentiation between vaccinated and infected animals. Adriaensen C, De Greve H, Tian JQ, De Craeye S, Gubbels E, Eeckhaut V, Van Immerseel F, Ducatelle R, Kumar M, Hernalsteens JP. Infect Immun; 2007 May; 75(5):2461-8. PubMed ID: 17261603 [Abstract] [Full Text] [Related]
25. M-01ZH09, an oral live attenuated Salmonella enterica serovar Typhi vaccine for the prevention of typhoid fever. Jain SK. Curr Opin Mol Ther; 2009 Oct; 11(5):565-71. PubMed ID: 19806505 [Abstract] [Full Text] [Related]
26. Concomitant induction of CD4+ and CD8+ T cell responses in volunteers immunized with Salmonella enterica serovar typhi strain CVD 908-htrA. Salerno-Gonçalves R, Wyant TL, Pasetti MF, Fernandez-Viña M, Tacket CO, Levine MM, Sztein MB. J Immunol; 2003 Mar 01; 170(5):2734-41. PubMed ID: 12594304 [Abstract] [Full Text] [Related]
27. Salmonella enterica serovar Typhimurium ruvB mutant can confer protection against salmonellosis in mice. Choi J, Shin D, Ryu S. Vaccine; 2010 Sep 07; 28(39):6436-44. PubMed ID: 20670908 [Abstract] [Full Text] [Related]
31. [Properties of 2 gal+ derivatives of the vaccine mutant gal E Ty21a strain of Salmonella typhi]. Silva-Salinas BA, Rodríguez-Aguayo L, Maldonado-Ballesteros A, Valenzuela-Montero ME, Seoane-Montecinos M. Bol Med Hosp Infant Mex; 1985 Apr 07; 42(4):234-9. PubMed ID: 4005022 [No Abstract] [Full Text] [Related]
32. Immune responses to an oral typhoid vaccine strain that is modified to constitutively express Vi capsular polysaccharide. Tacket CO, Pasetti MF, Sztein MB, Livio S, Levine MM. J Infect Dis; 2004 Aug 01; 190(3):565-70. PubMed ID: 15243933 [Abstract] [Full Text] [Related]
34. Cellular immunity against Salmonella typhi after live oral vaccine. Tagliabue A, Nencioni L, Caffarena A, Villa L, Boraschi D, Cazzola G, Cavalieri S. Clin Exp Immunol; 1985 Nov 01; 62(2):242-7. PubMed ID: 3878744 [Abstract] [Full Text] [Related]
37. Studies on immunogenicity and protective efficacy of DnaJ of Salmonella Typhi against lethal infection by Salmonella Typhimurium in mice. Sagi SS, Paliwal P, Bansal A, Mishra C, Khan N, Mustoori SR, Ilavazhagan G, Sawhney RC, Banerjee PK. Vaccine; 2006 Nov 30; 24(49-50):7135-41. PubMed ID: 16887241 [Abstract] [Full Text] [Related]
39. Constitutive expression of the Vi polysaccharide capsular antigen in attenuated Salmonella enterica serovar typhi oral vaccine strain CVD 909. Wang JY, Noriega FR, Galen JE, Barry E, Levine MM. Infect Immun; 2000 Aug 30; 68(8):4647-52. PubMed ID: 10899868 [Abstract] [Full Text] [Related]